Cargando…
Central nervous system hemangioblastomas in von Hippel-Lindau disease: Total growth rate and risk of developing new lesions not associated with circulating VEGF levels
BACKGROUND: Hemangioblastomas of the central nervous system are a prominent feature of von Hippel-Lindau-disease (vHL). Hemangioblastomas are known to secrete vascular endothelial growth factor (VEGF), suggesting a potential role of VEGF as a biomarker for tumor growth. METHODS: Plasma VEGF samples...
Autores principales: | Sundblom, Jimmy, Skare, Tor Persson, Holm, Olivia, Welin, Staffan, Braun, Madelene, Nilsson, Pelle, Enblad, Per, Sjöström, Elisabet Ohlin, Smits, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704563/ https://www.ncbi.nlm.nih.gov/pubmed/36441756 http://dx.doi.org/10.1371/journal.pone.0278166 |
Ejemplares similares
-
Resection of von Hippel Lindau Related Brainstem Hemangioblastoma
por: Maggio, Dominic, et al.
Publicado: (2019) -
Von Hippel-Lindau Syndrome: Diagnosis and Management of Hemangioblastoma and Pheochromocytoma
por: Vaganovs, P., et al.
Publicado: (2013) -
Hemangioblast: origin of hemangioblastoma in von Hippel-Lindau (VHL) syndrome
por: Wang, Herui, et al.
Publicado: (2018) -
Von Hippel-Lindau Disease: The Importance of Retinal Hemangioblastomas in Diagnosis
por: Şahin Atik, Sevinç, et al.
Publicado: (2017) -
Loss of Quiescence in von Hippel-Lindau Hemangioblastomas is Associated with Erythropoietin Signaling
por: Feldman, Michael J., et al.
Publicado: (2016)